NVAX241025C9000
- 1.07
- -0.07-6.14%
Novavax Newsroom
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
How Bad Is This News for Novavax?
Express News | EMA: Chmp Gave Positive Opinions to Update Composition of Nuvaxovid and Bimervax
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
Novavax Stock Plummets as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
Novavax Reports FDA Placed Clinical Hold on IND for COVID-flu Combo Vaccine
J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $9
Novavax's Regulatory Setback and Mid-Term Underperformance: An Analyst's Perspective
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Novavax pharmaceuticals plunged 20% as the US FDA paused its COVID/Influenza combination vaccine trial.
①After a severe motor neuron disorder event occurred in one of the study participants, the Food and Drug Administration (FDA) of the united states suspended the company's clinical trial of 'Influenza/COVID-19 combination vaccine'; ②Novavax claims that it is working with the FDA to resolve the clinical hold issue of its combination vaccine and separate influenza vaccine trials.
Novavax Analyst Ratings
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $25
Cautious Optimism for Novavax Amid Clinical Hold Challenges
Jefferies Cuts Novavax's Price Target to $25 From $31, Buy Rating Maintained
Swelling Losses Haven't Held Back Gains for Novavax (NASDAQ:NVAX) Shareholders Since They're up 190% Over 5 Years
Novavax Stock Dives as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Novavax Stock Tumbles 20% as FDA Pauses Clinical Trial on Security Concerns -- Barrons.com
These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, Novavax, J.B. Hunt, DJT, and More -- Barrons.com
Express News | US stocks opened basically flat, with the Dow down 0.10%, the Nasdaq up 0.08%, and the S&P 500 index up 0.01%. ASML Holding fell nearly 3% due to underperformance, with the stock dropping 16.26% yesterday. Morgan Stanley rose over 4%, with third-quarter n